GLPBio

Sphingolipids

Products Related to Sphingolipids(340)

  • GC43078 structure
    GC43078C24:1 Ceramide (d18:1/24:1(15Z))
    CAS: 54164-50-0
    Purity: >98.00%

    C24:1 Ceramide (d18:1/24:1(15Z)) est une céramide abondante qui existe naturellement et qui régule les nombreuses activités biologiques différentes, comme l'apoptose, la différenciation cellulaire, la prolifération des cellules musculaires lisses et l'inhibition de la chaîne respiratoire mitochondriale.

  • GC43080 structure
    GC43080C30 Ceramide (d18:1/30:0)
    CAS: 871540-97-5
    Purity: >98.00%

    C30 Ceramide is a naturally occurring ceramide that has been found in the stratum corneum of human and nude mouse skin.

  • GC43081 structure
    GC43081C30(ω-hydroxy) Ceramide (d18:1/30:0)
    CAS: 457100-08-2
    Purity: >98.00%

    C30(ω-hydroxy) Ceramide (d18:1/30:0), un sphingolipide, est un composant vital spécifique À l'épiderme de la barrière hydrique de la peau des mammifères.

  • GC43082 structure
    GC43082C32 Ceramide (d18:1/32:0)
    CAS: 34227-73-1
    Purity: >98.00%

    C32 Ceramide is a naturally occurring ceramide that has been found in the stratum corneum of human and nude mouse skin.

  • GC43084 structure
    GC43084C4 Ceramide (d18:1/4:0)
    CAS: 74713-58-9
    Purity: >95.00%

    C4 Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides.

  • GC43085 structure
    GC43085C6 Biotin 3'-sulfo Galactosylceramide (d18:1/6:0)
    Purity: >98%

    C6 Biotin 3'-sulfo galactosylceramide is an affinity probe that allows C6 3'-sulfo galactosylceramide to be detected or immobilized through interaction with the biotin ligand.

  • GC43086 structure
    GC43086C6 Biotin Ceramide (d18:1/6:0)
    CAS: 192070-02-3
    Purity: >98.00%

    C6 Ceramide-biotin is an affinity probe that allows C2 ceramide (d18:1/2:0) to be detected or immobilized through interaction with the biotin ligand.

  • GC43088 structure
    GC43088C6 Biotin Ganglioside GM1 (d18:1/6:0)
    Purity: >98.00%

    C6 Biotin ganglioside GM1 is an affinity probe that allows ganglioside GM1 to be detected or immobilized through interaction with the biotin ligand.

  • GC43089 structure
    GC43089C6 Biotin Glucosylceramide (d18:1/6:0)
    CAS: 2692623-22-4
    Purity: >98.00%

    C6 Biotin glucosylceramide is an affinity probe that allows C6 glucosylceramide to be detected or immobilized through interaction with the biotin ligand.

  • GC43090 structure
    GC43090C6 Biotin Lactosylceramide (d18:1/6:0)
    Purity: >98.00%

    C6 Biotin lactosylceramide is an affinity probe that allows C6 lactosylceramide to be detected or immobilized through interaction with the biotin ligand.

  • GC43091 structure
    GC43091C6 Ceramide (d18:1/6:0) Alkyne
    Purity: >95.00%

    C6 Ceramide alkyne is an ω-alkyne derivative of C6 ceramide.

  • GC43092 structure
    GC43092C6 dihydro Ceramide (d18:0/6:0)
    CAS: 171039-13-7
    Purity: >98.00%

    C6 dihydro Ceramide is a metabolically inactive analog of C6 ceramide that has been used as a negative control in experiments investigating the biological activity of C6 ceramide.

  • GC43096 structure
    GC43096C6 NBD Ceramide (d18:1/6:0)
    CAS: 94885-02-6
    Purity: >98.00%

    C6 NBD Ceramide (d18:1/6:0) est une sonde fluorescente pour appareil de Golgi avec perméabilité de la membrane cellulaire.

  • GC43097 structure
    GC43097C6 NBD dihydro Ceramide (d18:0/6:0)
    CAS: 114301-97-2
    Purity: >98.00%

    Le dihydro céramide C6 NBD (d18:0/6:0) est un analogue de la sphinganine et peut être utilisé comme colorant fluorescent pour le marquage des acides gras.

  • GC43098 structure
    GC43098C6 NBD Galactosylceramide (d18:1/6:0)
    CAS: 170212-26-7
    Purity: >98.00%

    Le galactosylcéramide C6 NBD est un dérivé actif du galactosylcéramide qui est marqué avec du nitrobenzoxadiazole C6 fluorescent (C6 NBD).

  • GC43099 structure
    GC43099C6 NBD Glucosylceramide (d18:1/6:0)
    CAS: 94885-03-7
    Purity: >98.00%

    Le glucosylcéramide C6 NBD (d18:1/6:0) est un dérivé fluorescent du glucosylcéramide (Ex=466 nm, Em=535 nm).

  • GC43100 structure
    GC43100C6 NBD Lactosylceramide (d18:1/6:0)
    CAS: 474943-04-9
    Purity: >98.00%

    Le lactosylcéramide C6 NBD (d18:1/6:0) est un dérivé des lactosylcéramides et peut être utilisé dans le dosage de la lactosylcéramide synthase en tant que substrat accepteur fluorescent. Le lactosylcéramide C6 NBD (d18:1/6:0) peut également être utilisé dans la recherche sur le cancer.

  • GC43101 structure
    GC43101C6 NBD L-threo Ceramide (d18:1/6:0)
    CAS: 114301-95-0
    Purity: >98.00%

    C6 NBD L-threo Ceramide (d18:1/6:0) est un céramide perméable À la membrane.

  • GC43102 structure
    GC43102C6 NBD L-threo dihydro Ceramide (d18:0/6:0)
    Purity: >98.00%

    C6 NBD L-threo dihydro ceramide is a sphingolipid that has been tagged with a fluorescent C6 nitrobenzoxadiazole group.

  • GC43103 structure
    GC43103C6 NBD Sphingomyelin (d18:1/6:0)
    CAS: 94885-04-8
    Purity: >98.00%

    C6 NBD Sphingomyelin (d18:1/6:0) est un analogue fluorescent À chaÎne courte de la sphingomyéline.

  • GC43104 structure
    GC43104C6 Phytoceramide (t18:0/6:0)
    CAS: 249728-94-7
    Purity: >98.00%

    C6 Phytoceramide is a cell-permeable analog of phytoceramide.

  • GC43106 structure
    GC43106C8 Ceramide-1-phosphate (d18:1/8:0)
    CAS: 158983-53-0
    Purity: >90.00%

    C8 ceramide-1-phosphate is a short-chain analog of the naturally occurring ceramide-1-phosphate.

  • GC43107 structure
    GC43107C8 Ceramine (d18:1/8:0)
    CAS: 170926-06-4
    Purity: >98.00%

    C8 Ceramine is an analog of C8 ceramide in which the carbonyl group of the ceramide is replaced by a methylene group.

  • GC43108 structure
    GC43108C8 dihydro Ceramide (d18:0/8:0)
    CAS: 145774-33-0
    Purity: >98.00%

    Le dihydro céramide C8 (d18:0/8:0) est un contrÔle négatif du céramide C8. Le C8-Céramide (N-Octanoyl-D-érythro-sphingosine) est un analogue perméable aux cellules des céramides naturels. C8-Céramide a des propriétés anti-prolifération et agit comme un puissant agent chimiothérapeutique. C8-Ceramide stimule les cellules dendritiques pour favoriser les réponses des lymphocytes T lors d'infections virales. C8-Céramide induit une légère activation de la protéine kinase (PKC) in vitro.